Bhallatakarishtha In Psoriasis

A pharmaceutical standardization of Bhallatakarishta prepared by Kanji and water as liquid media and their effect on Eka-Kushtha (Psoriasis)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017632

Enrollment

Registered

2019-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: GROUP A Bhallatakarishta prapred by Kanji: IN GROUP A Bhallatakarishtha prapred by water internally dose 10 ml twice a day along with gandhaka malahar externally will be given with an

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with all forms of Eka-kushtha (Psoriasis) with classical signs & symptoms of Eka-kushtha (Psoriasis) 2) All type of psoriasis will be included

Exclusion criteria

Exclusion criteria: 1)Age 60yrs. 2) Pregnant women 3) Uncontrolled Diabetes Mellitus & Hypertension 4) Any other serious systemic illness like AIDS, Malignancy etc •Patients who are not willing to be included in the study

Design outcomes

Primary

Measure	Time frame
Effect of Bhallatakarishta on Eka-kushtha (Psoriasis)Timepoint: 3 months	—

Secondary

Measure	Time frame
Comparative efficacy of bhallatakarishtha prepared by Kanji and water on EkakusthaTimepoint: 3 month	—

Countries

India

Contacts

Public Contactprof BJ Patgiri

IPGT AND RA

patgiri124@gmail.com9426947438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026